What is Palvella Therapeutics, Inc (PVLA) stock price today?

Palvella Therapeutics, Inc (PVLA) currently trades at $130.17 per share. The stock has a market capitalization of $1.82B and a P/E ratio of —x.

Is PVLA stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Palvella Therapeutics, Inc has a Smart Value Score of 23/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

PVLA

Palvella Therapeutics, Inc

NASDAQ: PVLA · HEALTHCARE · BIOTECHNOLOGY

$130.17

+0.54% today

Updated 2026-05-06

Market cap

$1.82B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-3.70

Dividend yield

—

52W range

$20 – $151

Volume

0.3M

Market cap

$1.82B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-3.70

Dividend yield

—

52W range

$20 – $151

Volume

0.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →197 stocks currently score above 75

Price targets

Analyst target

$230.07

+76.75%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy15 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-4.93M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$25.90M	$0.00	$0.00	$0.00	$0.00
Net income	$-33.28M	$18.69M	$-17.43M	$-41.72M	$-12.71M
EPS	—	—	—	—	$-3.70
Free cash flow	$-15.88M	$-13.70M	$-10.84M	$-25.01M	$-4.93M
Profit margin	-128.47%	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
PVLA	$1.82B	23	4.3	3.0	5.0	5.0	—	Avoid
LLY	$862.01B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$546.90B	59	4.7	9.0	3.3	6.0	-40.34%	Buy
ABBV	$365.43B	63	4.0	8.0	4.0	5.0	-22.55%	Buy
UNH	$336.72B	54	5.3	5.5	7.3	4.8	+43.12%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+3.99%	Buy

Smart narrative

Palvella Therapeutics, Inc trades at $130.17. Our Smart Value Score of 23/100 indicates the stock is weak.

Frequently asked questions

What is Palvella Therapeutics, Inc's stock price?

Palvella Therapeutics, Inc (PVLA) trades at $130.17.

Is Palvella Therapeutics, Inc overvalued?

Smart Value Score 23/100 (Grade F, Strong Sell).

What is the price target of Palvella Therapeutics, Inc (PVLA)?

The analyst target price is $230.07, representing +76.7% upside from the current price of $130.17.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-92.10%

Beta—

50D MA$124.75

200D MA$85.86

Shares out0.01B

Float0.01B

Short ratio—

Avg volume0.3M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

PVLA vs LLY →PVLA vs JNJ →PVLA vs ABBV →Stock screener →